A new report from a bipartisan psychedelics caucus in Congress summarizes stakeholders’ views on how the therapeutic use of substances like psilocybin, ibogaine and DMT can be “safely and ethically integrated” into the U.S. healthcare system, emphasizing the need for collaboration across federal agencies and with states. The document, published on Thursday by the Congressional […]